Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Korkmaz, T.; Seber, S.; KEFELİ, UMUT; Sari, E.; Canhoroz, M.; Oven, B.; Yildirim, E.; Yasar, N.; Aydin, D.; Balvan, O.; Sener, N.; Yuksel, S.; Mert, A.; Polat, O.; YUMUK, PERRAN; Kanat, O.; Gumus, M.; Turhal, N.

doi:10.1007/s12094-012-0960-6

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

Atıf İçin Kopyala

Korkmaz T., Seber S., KEFELİ U., Sari E., Canhoroz M., Oven B., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, sa.7, ss.535-540, 2013 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 7
Basım Tarihi: 2013
Doi Numarası: 10.1007/s12094-012-0960-6
Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.535-540
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.